| HGNC Family | CD molecules (CD) |
| Name | plasminogen activator, urokinase receptor |
| Description | This gene encodes the receptor for urokinase plasminogen activator and, given its role in localizing and promoting plasmin formation, likely influences many normal and pathological processes related to cell-surface plasminogen activation and localized degradation of the extracellular matrix. It binds both the proprotein and mature forms of urokinase plasminogen activator and permits the activation of the receptor-bound pro-enzyme by plasmin. The protein lacks transmembrane or cytoplasmic domains and may be anchored to the plasma membrane by a glycosyl-phosphatidylinositol (GPI) moiety following cleavage of the nascent polypeptide near its carboxy-terminus. However, a soluble protein is also produced in some cell types. Alternative splicing results in multiple transcript variants encoding different isoforms. The proprotein experiences several post-translational cleavage reactions that have not yet been fully defined. [provided by RefSeq, Jul 2008] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nThe urokinase‐type plasminogen activator receptor (uPAR), encoded by the PLAUR gene, plays a key role in kidney pathophysiology. Elevated levels of soluble uPAR (suPAR) have been implicated in primary focal segmental glomerulosclerosis (FSGS) by activating podocyte β3 integrin, leading to foot process effacement and proteinuria, and higher pre‐transplant suPAR levels predict FSGS recurrence. In addition, uPAR signaling in podocytes is essential for the development of proteinuria in response to inflammatory challenges. These studies also show that dynamic alterations in uPAR expression and cleavage contribute to glomerular disease progression by modulating the interaction between circulating suPAR and its integrin targets."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "5"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn the context of cancer biology, uPAR contributes significantly to tumor progression. Under hypoxic conditions, increased uPAR expression facilitates epithelial–mesenchymal transition (EMT), enhances cell migration and invasion, and promotes signaling cascades via integrin activation. uPAR directly interacts with extracellular matrix proteins such as vitronectin, modulating integrin-dependent cell adhesion and thereby fostering an invasive phenotype. These observations link uPAR signaling to matrix remodeling and metastatic behavior in various cancers."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "6", "end_ref": "9"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nStructural and molecular studies have provided detailed insights into uPAR functionality. High‐resolution crystal structures reveal a flexible, three‐domain architecture that allows uPAR to engage a variety of ligands including urokinase (uPA) and vitronectin, and to adopt multiple conformations that influence its binding affinities. Regulatory mechanisms at the mRNA level, including stabilization mediated by HuR binding to AU‐rich elements in the uPAR mRNA, further control its expression, while proteolytic cleavage of uPAR modulates its signaling capabilities."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "10", "end_ref": "13"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond kidney disease and cancer invasion, uPAR is an important mediator of diverse cellular processes. uPAR signaling modulates inflammation and cell migration by interacting with integrins and other co‐receptors, thereby activating kinases such as Akt, ERK, and small GTPases (e.g., Rac1). This receptor is also linked to post‐transcriptional regulation and is negatively regulated by tumor suppressors such as Pdcd4. MicroRNAs further influence uPAR expression, contributing to shifts in the invasive potential of tumor cells."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "14", "end_ref": "18"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nuPAR’s interplay with integrins and extracellular proteolytic systems further underlies its impact on cell adhesion and migration. It directly associates with integrins such as α5β1 and αvβ3 to modify fibronectin or vitronectin binding, rendering cell–matrix adhesions resistant to conventional inhibitory peptides. In various cancers including head and neck and gastric carcinomas, uPAR and its downstream effectors promote angiogenesis and metastasis, while its overexpression in pancreatic and other aggressive tumors correlates with invasive behavior. Additionally, uPAR mediates leukocyte responses, contributing to inflammatory cell recruitment."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "19", "end_ref": "24"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nFunctional studies using genetic and pharmacologic approaches further establish the centrality of uPAR in mediating signal transduction and cell fate decisions. Interference with uPAR–integrin interactions diminishes ERK activation and matrix metalloproteinase expression; RNAi-mediated down-regulation of uPAR and uPA triggers apoptotic pathways and reduces tumor cell invasiveness. In fibroblasts, the integrity of full-length uPAR is critical for modulating transitions to myofibroblast phenotypes, emphasizing its role in tissue remodeling and wound repair."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "25", "end_ref": "30"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nFinally, uPAR is emerging as a promising therapeutic target, especially in brain malignancies and infectious diseases. Interactions between uPAR and novel ligands—notably SRPX2 in epilepsy and aberrant uPAR-mediated signaling in response to endotoxins—have expanded our understanding of its function in neurobiology and systemic inflammation. Moreover, conjugates that specifically target uPAR-positive tumor cells have shown preclinical efficacy. Such strategies, which exploit uPAR’s multifaceted role in mitogenesis and metastasis, highlight its potential in targeted intervention across a spectrum of uPAR-driven pathologies."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "31", "end_ref": "35"}]}, {"type": "t", "text": ""}]}]}]}]}]}]}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Changli Wei, Shafic El Hindi, Jing Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Med (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nm.2411"}], "href": "https://doi.org/10.1038/nm.2411"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21804539"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21804539"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Changli Wei, Clemens C Möller, Mehmet M Altintas, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Modification of kidney barrier function by the urokinase receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Med (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nm1696"}], "href": "https://doi.org/10.1038/nm1696"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18084301"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18084301"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Changli Wei, Howard Trachtman, Jing Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circulating suPAR in two cohorts of primary FSGS."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Am Soc Nephrol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1681/ASN.2012030302"}], "href": "https://doi.org/10.1681/ASN.2012030302"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23138488"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23138488"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Carlos R Franco Palacios, John C Lieske, Hani M Wadei, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Transplantation (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/TP.0b013e3182977ab1"}], "href": "https://doi.org/10.1097/TP.0b013e3182977ab1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23736353"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23736353"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Jing Huang, Gang Liu, Yi-Miao Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Plasma soluble urokinase receptor levels are increased but do not distinguish primary from secondary focal segmental glomerulosclerosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Kidney Int (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ki.2013.55"}], "href": "https://doi.org/10.1038/ki.2013.55"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23447064"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23447064"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Robin D Lester, Minji Jo, Valérie Montel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "uPAR induces epithelial-mesenchymal transition in hypoxic breast cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1083/jcb.200701092"}], "href": "https://doi.org/10.1083/jcb.200701092"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17664334"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17664334"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Chris D Madsen, Gian Maria Sarra Ferraris, Annapaola Andolfo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "uPAR-induced cell adhesion and migration: vitronectin provides the key."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1083/jcb.200612058"}], "href": "https://doi.org/10.1083/jcb.200612058"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17548516"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17548516"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Daniela Alfano, Paola Franco, Immacolata Vocca, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The urokinase plasminogen activator and its receptor: role in cell growth and apoptosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Thromb Haemost (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1160/TH04-09-0592"}], "href": "https://doi.org/10.1160/TH04-09-0592"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15711734"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15711734"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Songdong Meng, Debu Tripathy, Sanjay Shete, et al. "}, {"type": "b", "children": [{"type": "t", "text": "uPAR and HER-2 gene status in individual breast cancer cells from blood and tissues."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0608113103"}], "href": "https://doi.org/10.1073/pnas.0608113103"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17079488"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17079488"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Qing Huai, Andrew P Mazar, Alice Kuo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structure of human urokinase plasminogen activator in complex with its receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Science (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/science.1121143"}], "href": "https://doi.org/10.1126/science.1121143"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16456079"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16456079"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Hoanh Tran, Fabienne Maurer, Yoshikuni Nagamine "}, {"type": "b", "children": [{"type": "t", "text": "Stabilization of urokinase and urokinase receptor mRNAs by HuR is linked to its cytoplasmic accumulation induced by activated mitogen-activated protein kinase-activated protein kinase 2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.23.20.7177-7188.2003"}], "href": "https://doi.org/10.1128/MCB.23.20.7177-7188.2003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14517288"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14517288"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Nunzia Montuori, Maria Vincenza Carriero, Salvatore Salzano, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The cleavage of the urokinase receptor regulates its multiple functions."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M207494200"}], "href": "https://doi.org/10.1074/jbc.M207494200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12297505"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12297505"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Margarita Gutova, Joseph Najbauer, Anna Gevorgyan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of uPAR-positive chemoresistant cells in small cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0000243"}], "href": "https://doi.org/10.1371/journal.pone.0000243"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17327908"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17327908"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Salim S Hayek, Kwi Hye Koh, Morgan E Grams, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A tripartite complex of suPAR, APOL1 risk variants and α"}, {"type": "a", "children": [{"type": "t", "text": "sub"}], "href": "sub"}, {"type": "t", "text": "v"}, {"type": "a", "children": [{"type": "t", "text": "/sub"}], "href": "/sub"}, {"type": "t", "text": "β"}, {"type": "a", "children": [{"type": "t", "text": "sub"}], "href": "sub"}, {"type": "t", "text": "3"}, {"type": "a", "children": [{"type": "t", "text": "/sub"}], "href": "/sub"}, {"type": "t", "text": " integrin on podocytes mediates chronic kidney disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Med (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nm.4362"}], "href": "https://doi.org/10.1038/nm.4362"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28650456"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28650456"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Lihua Sun, Wei Yan, Yingyi Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-10b induces glioma cell invasion by modulating MMP-14 and uPAR expression via HOXD10."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Brain Res (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.brainres.2011.03.013"}], "href": "https://doi.org/10.1016/j.brainres.2011.03.013"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21419107"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21419107"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Chelsea L Loughner, Elspeth A Bruford, Monica S McAndrews, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Organization, evolution and functions of the human and mouse Ly6/uPAR family genes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Genomics (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s40246-016-0074-2"}], "href": "https://doi.org/10.1186/s40246-016-0074-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27098205"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27098205"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "J H Leupold, H-S Yang, N H Colburn, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.onc.1210234"}], "href": "https://doi.org/10.1038/sj.onc.1210234"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17297470"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17297470"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Minji Jo, Robin D Lester, Valerie Montel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Reversibility of epithelial-mesenchymal transition (EMT) induced in breast cancer cells by activation of urokinase receptor-dependent cell signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M109.023960"}], "href": "https://doi.org/10.1074/jbc.M109.023960"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19546228"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19546228"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Ying Wei, Ralf-Peter Czekay, Liliane Robillard, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of alpha5beta1 integrin conformation and function by urokinase receptor binding."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1083/jcb.200404112"}], "href": "https://doi.org/10.1083/jcb.200404112"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15684035"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15684035"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Miguel Angel Pavón, Irene Arroyo-Solera, Maria Virtudes Céspedes, et al. "}, {"type": "b", "children": [{"type": "t", "text": "uPA/uPAR and SERPINE1 in head and neck cancer: role in tumor resistance, metastasis, prognosis and therapy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.10344"}], "href": "https://doi.org/10.18632/oncotarget.10344"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27385000"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27385000"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Takeshi Kaneko, Hiroyuki Konno, Megumi Baba, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Urokinase-type plasminogen activator expression correlates with tumor angiogenesis and poor outcome in gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Sci (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1349-7006.2003.tb01350.x"}], "href": "https://doi.org/10.1111/j.1349-7006.2003.tb01350.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12708473"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12708473"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Moitza Principe, Simone Borgoni, Mariafrancesca Cascione, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Hematol Oncol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13045-016-0385-8"}], "href": "https://doi.org/10.1186/s13045-016-0385-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28086938"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28086938"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Evi X Stavrou, Chao Fang, Kara L Bane, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Factor XII and uPAR upregulate neutrophil functions to influence wound healing."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI92880"}], "href": "https://doi.org/10.1172/JCI92880"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29376892"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29376892"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Bernard Degryse, Massimo Resnati, Ralf-Peter Czekay, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Domain 2 of the urokinase receptor contains an integrin-interacting epitope with intrinsic signaling activity: generation of a new integrin inhibitor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M413954200"}], "href": "https://doi.org/10.1074/jbc.M413954200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15863511"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15863511"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Elzbieta Pluskota, Dmitry A Soloviev, Edward F Plow "}, {"type": "b", "children": [{"type": "t", "text": "Convergence of the adhesive and fibrinolytic systems: recognition of urokinase by integrin alpha Mbeta 2 as well as by the urokinase receptor regulates cell adhesion and migration."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2002-06-1842"}], "href": "https://doi.org/10.1182/blood-2002-06-1842"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12393547"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12393547"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Hari Raghu, Prasanna Kumar Sodadasu, Rama Rao Malla, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Localization of uPAR and MMP-9 in lipid rafts is critical for migration, invasion and angiogenesis in human breast cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cancer (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1471-2407-10-647"}], "href": "https://doi.org/10.1186/1471-2407-10-647"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21106094"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21106094"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Ying Wei, Chi-Hui Tang, Young Kim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Urokinase receptors are required for alpha 5 beta 1 integrin-mediated signaling in tumor cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M607989200"}], "href": "https://doi.org/10.1074/jbc.M607989200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17145753"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17145753"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Carmine Selleri, Nunzia Montuori, Patrizia Ricci, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Involvement of the urokinase-type plasminogen activator receptor in hematopoietic stem cell mobilization."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2004-06-2424"}], "href": "https://doi.org/10.1182/blood-2004-06-2424"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15494432"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15494432"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Christopher S Gondi, Neelima Kandhukuri, Dzung H Dinh, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Down-regulation of uPAR and uPA activates caspase-mediated apoptosis and inhibits the PI3K/AKT pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Oncol (2007)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17549401"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17549401"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Audrey M Bernstein, Sally S Twining, Debra J Warejcka, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Urokinase receptor cleavage: a crucial step in fibroblast-to-myofibroblast differentiation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Biol Cell (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1091/mbc.e06-10-0912"}], "href": "https://doi.org/10.1091/mbc.e06-10-0912"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17507651"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17507651"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Harvey W Smith, Pierfrancesco Marra, Christopher J Marshall "}, {"type": "b", "children": [{"type": "t", "text": "uPAR promotes formation of the p130Cas-Crk complex to activate Rac through DOCK180."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1083/jcb.200712050"}], "href": "https://doi.org/10.1083/jcb.200712050"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18725541"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18725541"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Daniel A Vallera, Chunbin Li, Ni Jin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Targeting urokinase-type plasminogen activator receptor on human glioblastoma tumors with diphtheria toxin fusion protein DTAT."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Natl Cancer Inst (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/jnci/94.8.597"}], "href": "https://doi.org/10.1093/jnci/94.8.597"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11959893"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11959893"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "S D Killeen, J H Wang, E J Andrews, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Bacterial endotoxin enhances colorectal cancer cell adhesion and invasion through TLR-4 and NF-kappaB-dependent activation of the urokinase plasminogen activator system."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Cancer (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.bjc.6604942"}], "href": "https://doi.org/10.1038/sj.bjc.6604942"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19436306"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19436306"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Minji Jo, Keena S Thomas, Nadzeya Marozkina, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dynamic assembly of the urokinase-type plasminogen activator signaling receptor complex determines the mitogenic activity of urokinase-type plasminogen activator."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M413141200"}], "href": "https://doi.org/10.1074/jbc.M413141200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15728176"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15728176"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Qin Wang, Yunshan Wang, Yi Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The role of uPAR in epithelial-mesenchymal transition in small airway epithelium of patients with chronic obstructive pulmonary disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Respir Res (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1465-9921-14-67"}], "href": "https://doi.org/10.1186/1465-9921-14-67"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23806081"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23806081"}]}]}]}
|
| Synonyms | U-PAR, URKR, CD87, UPAR |
| Proteins | UPAR_HUMAN |
| NCBI Gene ID | 5329 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
PLAUR has 15,833 functional associations with biological entities spanning 8 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 130 datasets.
Click the + buttons to view associations for PLAUR from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of PLAUR gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of PLAUR gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PLAUR gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of PLAUR gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of PLAUR gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of PLAUR gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of PLAUR gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PLAUR gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PLAUR gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of PLAUR gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of PLAUR gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of PLAUR gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with PLAUR protein from the CCLE Cell Line Proteomics dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with PLAUR gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of PLAUR gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of PLAUR gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of PLAUR gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of PLAUR gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of PLAUR gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing PLAUR protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing PLAUR protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with PLAUR protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with PLAUR protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| CORUM Protein Complexes | protein complexs containing PLAUR protein from the CORUM Protein Complexes dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of PLAUR gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with PLAUR gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with PLAUR gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with PLAUR gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| dbGAP Gene-Trait Associations | traits associated with PLAUR gene in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset. | |
| DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of PLAUR protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by PLAUR gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DGIdb Drug Targets 2026 | interacting drugs for PLAUR protein from the DGIdb Drug Targets 2026 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with PLAUR gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with PLAUR gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with PLAUR gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with PLAUR gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| DrugBank Drug Targets | interacting drugs for PLAUR protein from the curated DrugBank Drug Targets dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at PLAUR gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of PLAUR gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of PLAUR gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing PLAUR from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with PLAUR gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with PLAUR gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of PLAUR gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with PLAUR gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing PLAUR from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of PLAUR gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of PLAUR gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of PLAUR gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of PLAUR gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of PLAUR gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of PLAUR gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving PLAUR gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving PLAUR gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving PLAUR gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing PLAUR protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing PLAUR protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing PLAUR protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by PLAUR gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of PLAUR gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of PLAUR gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PLAUR gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with PLAUR gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with PLAUR gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with PLAUR gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of PLAUR gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of PLAUR gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of PLAUR gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of PLAUR protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PLAUR gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for PLAUR from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuBMAP ASCT+B Annotations | cell types associated with PLAUR gene from the HuBMAP ASCT+B dataset. | |
| HuBMAP ASCT+B Augmented with RNA-seq Coexpression | cell types associated with PLAUR gene from the HuBMAP ASCT+B Augmented with RNA-seq Coexpression dataset. | |
| HuBMAP Azimuth Cell Type Annotations | cell types associated with PLAUR gene from the HuBMAP Azimuth Cell Type Annotations dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with PLAUR gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| IMPC Knockout Mouse Phenotypes | phenotypes of mice caused by PLAUR gene knockout from the IMPC Knockout Mouse Phenotypes dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for PLAUR protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of PLAUR gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of PLAUR gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of PLAUR gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEGG Pathways | pathways involving PLAUR protein from the KEGG Pathways dataset. | |
| KEGG Pathways 2026 | pathways involving PLAUR protein from the KEGG Pathways 2026 dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of PLAUR gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of PLAUR gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with PLAUR gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of PLAUR gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of PLAUR gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of PLAUR gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of PLAUR gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing PLAUR protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain PLAUR protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by PLAUR gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting PLAUR gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of PLAUR gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of PLAUR gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by PLAUR gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of PLAUR gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of PLAUR gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| PANTHER Pathways | pathways involving PLAUR protein from the PANTHER Pathways dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for PLAUR from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of PLAUR gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of PLAUR gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving PLAUR protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving PLAUR protein from the Wikipathways PFOCR 2024 dataset. | |
| PID Pathways | pathways involving PLAUR protein from the PID Pathways dataset. | |
| Reactome Pathways 2014 | pathways involving PLAUR protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving PLAUR protein from the Reactome Pathways 2024 dataset. | |
| Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of PLAUR gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of PLAUR gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of PLAUR gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PLAUR gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at PLAUR gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of PLAUR gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of PLAUR gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of PLAUR gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sanger Dependency Map Cancer Cell Line Proteomics | cell lines associated with PLAUR protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of PLAUR gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of PLAUR gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of PLAUR gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of PLAUR gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of PLAUR gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of PLAUR gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of PLAUR protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of PLAUR protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of PLAUR protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of PLAUR protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with PLAUR protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with PLAUR protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2014 | pathways involving PLAUR protein from the Wikipathways Pathways 2014 dataset. | |
| WikiPathways Pathways 2024 | pathways involving PLAUR protein from the WikiPathways Pathways 2024 dataset. | |